Welcome to Conversations in Drug Development, brought to you by the team at Boyds for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development. This podcast series features candid conversations from the expert team at Boyds, who are at the forefront of cutting-edge science and drug development in the pharmaceutical and biotechnology sector.
…
continue reading
Conversations in Software Development is a podcast intended primarily for students (at any level) who want to learn more about software development, especially if they intend to pursue a career in that field. More specifically, the goal of the podcast is to expose students to topics and ideas that they don't usually get to see or practice in a classroom setting, including many aspects of software development that are not related to coding. In each episode, we have a conversation with someone ...
…
continue reading
1
How are GMO regulations impacting clinical development in Europe?
24:36
24:36
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
24:36
In this episode of Conversations in Drug Development, our host Dr Harriet Edwards, is joined by Director of Regulatory Affairs, Dr Sabine Ruehle, to discuss the challenges of navigating genetically modified organism (GMO) regulations in clinical trials within Europe. This discussion helps decipher the nuanced environment of GMOs and their associate…
…
continue reading
1
US drug development: The latest regulatory trends and initiatives
22:38
22:38
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
22:38
In this episode of Conversations in Drug Development, host Dr Harriet Edwards is joined by Katy Rudnick and Dr Julie Warner from Boyds to discuss US regulatory trends and initiatives at the FDA. This episode explores the FDA's recent organizational changes, pilot programs, and focus on innovative clinical trials, including the use of AI in drug dis…
…
continue reading
1
The regulatory challenges of rare disease drug development
29:37
29:37
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
29:37
To celebrate Rare Disease Day, we are back with another Conversation in Drug Development, this time discussing the unique challenges of rare disease drug development. Dr Eric Hardter, Associate Director of Regulatory Affairs at Boyds, joins our host Harriet Edwards to explore the need for early stakeholder involvement, the complexities of pediatric…
…
continue reading
1
The drug development landscape: Trends and predictions for 2024
25:40
25:40
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
25:40
We are kickstarting 2024 with a Conversation in Drug Development with CEO and Founder of Boyds, Professor Alan Boyd. In this podcast episode, our host Harriet Edwards, and Professor Alan Boyd discuss trends from 2023 in the drug development space and its potential evolution in 2024. Join us as we explore the financial downturn affecting early-stage…
…
continue reading
1
Off-the-shelf cell therapies: Breaking barriers and revolutionizing patient care
20:30
20:30
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
20:30
In this episode of "Conversations in Drug Development", Harriet Edwards and Dr. Patrick Ginty discuss off-the-shelf cell therapies, explaining how these therapies are manufactured and their ability to treat multiple recipients. While these therapies offer scalability and the potential to treat larger patient populations, they also carry risks such …
…
continue reading
1
The future of drug development: AI’s role in revolutionizing the industry
22:13
22:13
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
22:13
In this episode of Conversations in Drug Development, Dr. Julie Warner and Harriet Edwards discuss the revolutionizing role of artificial intelligence (AI) in drug development, exploring its applications in data analysis and toxicity prediction, and its potential to reduce animal testing. Join us in this conversation, as we discuss the challenges o…
…
continue reading
1
Recent trends in oncology drug development
24:43
24:43
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
24:43
In this episode of Conversations in Drug Development, Dr Katherine Bowen and Dr Julie Warner delve deep into the ever-evolving world of oncology drug development and the regulatory landscape in the US and EU. Join us in this conversation, as we cover the key shifts in the field over the past few decades, regulatory challenges, FDA initiatives and f…
…
continue reading
In Episode 004: “Working in a Product Development Team” with Jenny Farver, we spoke with Jenny Farver about product development, including the various roles that you find in a product development team. Jenny herself has been the CTO of several companies and, in this bonus content from Episode 004, Jenny tells us more about the role of the CTO.…
…
continue reading
1
Episode 004: “Working in a Product Development Team” with Jenny Farver
21:22
21:22
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
21:22
More often than not, software development projects are actually product development projects. The goal is to develop a product that will actually be used, and where our users will have specific needs. The team that develops that product will involve more than just software developers and, to help us explore what product development entails, and the…
…
continue reading
In this bonus content from Episode 003: "The Business of Software Development" with Q McCallum, Q shares some of the lessons he learned early in his career and, indeed, how his early years in tech shaped many aspects of his career later on.Oleh Borja Sotomayor, Q McCallum
…
continue reading
1
Extras 003.1: "Do you need a CS degree to succeed in tech?"
8:29
8:29
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
8:29
In this bonus content from Episode 003: "The Business of Software Development" with Q McCallum, Q tells us about what he did (and didn't) learn in college, and whether you necessarily need a Computer Science degree to succeed in the tech industry.Oleh Borja Sotomayor, Q McCallum
…
continue reading
1
Episode 003: "The Business of Software Development" with Q McCallum
24:46
24:46
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
24:46
In this episode, we will be discussing the business of software development. Writing software doesn’t happen in a vacuum, it often happens in the context of a business, and it can be useful to understand exactly where software fits in a business. To explore this topic, I sat down with Q McCallum, a data consultant who started his career in the soft…
…
continue reading
1
Episode 002: "Giving and Receiving Feedback" with Chelsea Troy
21:00
21:00
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
21:00
In this episode, I sit down with Chelsea Troy, a Chicago-based software engineer, to talk about giving and receiving feedback, something you have to do quite often when working on software, but which you don’t always get to do as a student. Besides talking about code reviews, the most common situation where you have to give or receive feedback, we …
…
continue reading
1
Extras 001.1: "Working in Teams... Remotely"
8:47
8:47
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
8:47
In this bonus content from Episode 001: "Working in Teams" with Ben Collins-Sussman and Brian Fitzpatrick, Ben and Fitz tell us about the challenges of working remotely in a software team, especially in the context of a global crisis that is forcing nearly everyone to interact with their software teams remotely.…
…
continue reading
1
Episode 001: "Working in Teams" with Ben Collins-Sussman and Brian Fitzpatrick
29:16
29:16
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
29:16
Software development is a team sport and, for this inaugural episode of "Conversations in Software Development", we are very lucky to have a conversation on this subject with Ben Collins-Sussman and Brian "Fitz" Fitzpatrick. Besides being accomplished software engineers, Ben and Fitz have collaborated on multiple talks and books regarding the socia…
…
continue reading